FI964019A0 - Kinolonijohdannainen virtsainkontinenssin hoitoon - Google Patents

Kinolonijohdannainen virtsainkontinenssin hoitoon

Info

Publication number
FI964019A0
FI964019A0 FI964019A FI964019A FI964019A0 FI 964019 A0 FI964019 A0 FI 964019A0 FI 964019 A FI964019 A FI 964019A FI 964019 A FI964019 A FI 964019A FI 964019 A0 FI964019 A0 FI 964019A0
Authority
FI
Finland
Prior art keywords
urinary incontinence
treatment
quinolone derivatives
quinolone
derivatives
Prior art date
Application number
FI964019A
Other languages
English (en)
Swedish (sv)
Other versions
FI114705B (fi
FI964019A (fi
Inventor
John Edward Warawa
Jr Cyrus John Ohnmacht
Diane Amy Trainor
James Michael Hulsizer
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of FI964019A publication Critical patent/FI964019A/fi
Publication of FI964019A0 publication Critical patent/FI964019A0/fi
Application granted granted Critical
Publication of FI114705B publication Critical patent/FI114705B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI964019A 1994-04-14 1996-10-07 Kinolonijohdannainen virtsainkontinenssin hoitoon FI114705B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9407432 1994-04-14
GB9407432A GB9407432D0 (en) 1994-04-14 1994-04-14 Heterocyclic derivative
GB9500845 1995-04-13
PCT/GB1995/000845 WO1995028388A1 (en) 1994-04-14 1995-04-13 Quinolone derivative for treatment of urinary incontinence

Publications (3)

Publication Number Publication Date
FI964019A FI964019A (fi) 1996-10-07
FI964019A0 true FI964019A0 (fi) 1996-10-07
FI114705B FI114705B (fi) 2004-12-15

Family

ID=10753541

Family Applications (2)

Application Number Title Priority Date Filing Date
FI964019A FI114705B (fi) 1994-04-14 1996-10-07 Kinolonijohdannainen virtsainkontinenssin hoitoon
FI20040352A FI115630B (fi) 1994-04-14 2004-03-04 Menetelmä 4-(3-syaanifenyyli)-trifluorimetyyli-5-okso-1,4,5,6,7,8-heksahydrokinoliini-3-karboksyylihapon valmistamiseksi

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI20040352A FI115630B (fi) 1994-04-14 2004-03-04 Menetelmä 4-(3-syaanifenyyli)-trifluorimetyyli-5-okso-1,4,5,6,7,8-heksahydrokinoliini-3-karboksyylihapon valmistamiseksi

Country Status (25)

Country Link
EP (1) EP0755382B1 (fi)
JP (1) JP3782445B2 (fi)
KR (1) KR100344885B1 (fi)
CN (1) CN1058708C (fi)
AT (1) ATE202089T1 (fi)
AU (1) AU700773B2 (fi)
BR (1) BR9507366A (fi)
CA (1) CA2187525C (fi)
CZ (1) CZ284652B6 (fi)
DE (1) DE69521310T2 (fi)
DK (1) DK0755382T3 (fi)
ES (1) ES2159633T3 (fi)
FI (2) FI114705B (fi)
GB (1) GB9407432D0 (fi)
GR (1) GR3036482T3 (fi)
HK (1) HK1013999A1 (fi)
HU (1) HU215387B (fi)
MX (1) MX9603920A (fi)
NO (1) NO307177B1 (fi)
NZ (1) NZ283779A (fi)
PL (2) PL183095B1 (fi)
PT (1) PT755382E (fi)
RU (1) RU2149870C1 (fi)
SK (1) SK281124B6 (fi)
WO (1) WO1995028388A1 (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60036476T2 (de) * 1999-08-03 2008-06-12 Abbott Laboratories, Abbott Park Kalium kanalaktivatoren
EP1307429B1 (en) * 2000-08-02 2007-11-28 AstraZeneca AB Process for asymmetric synthesis of substituted 1,4-dihydropyridines
SE0200205D0 (sv) * 2002-01-24 2002-01-24 Astrazeneca Ab Method
CN102532015B (zh) * 2012-01-18 2013-10-23 云南大学 香豆素及其类似物的固相合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2003148A1 (de) * 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
GB9220570D0 (en) * 1991-10-21 1992-11-11 Ici Plc Therapeutic agent
GB9318935D0 (en) * 1992-10-20 1993-10-27 Zeneca Ltd Heterocyclic derivatives

Also Published As

Publication number Publication date
NO307177B1 (no) 2000-02-21
CA2187525C (en) 2006-01-24
DE69521310D1 (de) 2001-07-19
FI20040352A (fi) 2004-03-04
PL182031B1 (pl) 2001-10-31
KR100344885B1 (ko) 2002-11-30
GB9407432D0 (en) 1994-06-08
JPH09512254A (ja) 1997-12-09
EP0755382A1 (en) 1997-01-29
DK0755382T3 (da) 2001-09-10
PL183095B1 (pl) 2002-05-31
PL316790A1 (en) 1997-02-17
GR3036482T3 (en) 2001-11-30
CN1146202A (zh) 1997-03-26
SK281124B6 (sk) 2000-12-11
HUT76132A (en) 1997-06-30
BR9507366A (pt) 1997-09-23
FI114705B (fi) 2004-12-15
AU2219995A (en) 1995-11-10
MX9603920A (es) 1997-04-30
CZ298196A3 (en) 1997-02-12
RU2149870C1 (ru) 2000-05-27
CN1058708C (zh) 2000-11-22
NO964345D0 (no) 1996-10-11
DE69521310T2 (de) 2002-04-18
CZ284652B6 (cs) 1999-01-13
PT755382E (pt) 2001-11-30
EP0755382B1 (en) 2001-06-13
FI964019A (fi) 1996-10-07
CA2187525A1 (en) 1995-10-26
HU9602747D0 (en) 1996-11-28
ATE202089T1 (de) 2001-06-15
NO964345L (no) 1996-12-11
WO1995028388A1 (en) 1995-10-26
HU215387B (hu) 1998-12-28
ES2159633T3 (es) 2001-10-16
FI115630B (fi) 2005-06-15
AU700773B2 (en) 1999-01-14
SK131796A3 (en) 1997-05-07
HK1013999A1 (en) 1999-09-17
JP3782445B2 (ja) 2006-06-07
NZ283779A (en) 1998-02-26

Similar Documents

Publication Publication Date Title
FR12C0004I1 (fi)
DE69725484D1 (de) Vorrichtung zur Behandlung von Harninkontinenz
NL300433I1 (en) Methods and compositions for the treatment of glomerulonephritis
KR0145958B1 (en) Antibacterial agents
EP1407768A3 (en) The potassium channel opener retigabine for the treatment of diseases
EE9700267A (et) a1L- agonistide kasutamine uriiniinkontinentsuse raviks
AUPM761094A0 (en) Treatment of hides
FI964019A0 (fi) Kinolonijohdannainen virtsainkontinenssin hoitoon
EP0938898A3 (en) Treatment of pruritus
NZ509051A (en) Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use
CA2282682A1 (en) Tazarotene and corticosteroid treatment for psoriasis
ZA971600B (en) Treatment of macular edema.
AU3848797A (en) Process and composition for the antiparasitic treatment of the surroundings of animals
AU3290200A (en) Treatment agents for textiles, method of producing same and their use
WO2002020031A3 (de) Verfahren von erythropoietin sowie dessen derivate zur behandlung von schizophrenie und verwandten psychosen
AU4882897A (en) Disinfectant composition, particularly for the prevention of dermatitis induced by diapers, and method for its use
ZA974386B (en) New formulation for treatment of thromboembolism.
UA42749C2 (uk) N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування
ATE161814T1 (de) Mittel zur behandlung von bioabfällen
AU3247995A (en) Treatment of hides
SI0874843T1 (en) Substituted 4-(1h-benzimidazol-2-yl) 1,4)diazepanes useful for the treatment of allergic diseases
AU3974597A (en) Composition, process and method for treating grass by foliar application